Activ Surgical
- Industry
- Medical Technology
- Founded Year
- 2017
- Headquarters
- Boston, Massachusetts, USA
- Employee Count
- 50
Key People
- Todd Usen - Chief Executive Officer
- Peter Kim - Chief Financial Officer
- Manisha Shah-Bugaj - Chief Operating Officer
- Tom Calef - Chief Technology Officer
- Catherine Andrews - Vice President of Marketing
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises seasoned professionals with extensive experience in the medical technology sector.
Activ Surgical's executive team includes individuals with proven track records in MedTech, such as CEO Todd Usen, who has held leadership roles in prominent medical device companies. This collective experience positions the company well for navigating the complexities of the medical technology landscape.
- Clinical Need
-
Aspect: Very Strong
Summary: ActivSight addresses a critical need for enhanced surgical visualization to improve patient outcomes.
Surgical errors due to limited visibility can lead to significant patient morbidity. ActivSight's technology offers surgeons enhanced visualization, potentially reducing errors and improving safety, thereby fulfilling a substantial clinical need.
- Competition
-
Aspect: Somewhat crowded
Summary: The surgical visualization market has several players, but ActivSight offers unique features.
While there are multiple companies offering surgical visualization tools, ActivSight's real-time physiological insights provide a distinct advantage. However, maintaining this edge requires continuous innovation and adaptation to market demands.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing real-time imaging technology involves moderate technical challenges.
The integration of advanced imaging technologies into surgical workflows presents challenges in terms of accuracy, latency, and user-friendliness. Activ Surgical must address these to ensure widespread adoption.
- Patent
-
Aspect: Strong
Summary: The company holds strong patents protecting its core technologies.
Activ Surgical's patents cover key aspects of their technology, offering protection against competitors and potential licensing opportunities. This strengthens their market position and attractiveness to investors.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding from reputable investors.
With investments from firms like ARTIS Ventures and strategic partners like Mayo Clinic, Activ Surgical is well-positioned financially to advance its technology and expand its market presence.
- Regulatory
-
Aspect: 510k/PMA
Summary: ActivSight has received FDA clearance, facilitating market entry.
Obtaining FDA clearance indicates that ActivSight meets safety and efficacy standards, allowing the company to market its product in the U.S. This approval is crucial for building trust with healthcare providers and patients.
Opportunity Rollup
- Odds of Success
- 3.4
- Peak Market Share
- 4.3
- Segment CAGR
- 10.7%
- Market Segment
- Surgical Visualization
- Market Sub Segment
- Real-time Imaging Systems
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.22 |
| 2 | 0.64 |
| 3 | 1.50 |
| 4 | 3.01 |
| 5 | 4.30 |
Key Takeaway
Activ Surgical's innovative technology addresses a critical need in surgical visualization, supported by a strong team and financial backing, positioning it well in a competitive market.